Rodney Dawson
0000-0001-9804-1588
Publication & Citation Trends
Publications
0 total
Author Correction: Risk-stratified treatment for drug-susceptible pulmonary tuberculosis OA
Cited by 0
Semantic Scholar
Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosis
Cited by 3
Semantic Scholar
Efficacy and Safety of 4-Month Rifapentine-Based Tuberculosis Treatments in Persons with Diabetes
Cited by 1
Semantic Scholar
Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016–2020
Cited by 0
Semantic Scholar
Twice-Daily Dolutegravir Based Antiretroviral Therapy with One Month of Daily Rifapentine and Isoniazid (1HP) for TB Prevention.
Cited by 3
Semantic Scholar
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial. OA
Cited by 30
Semantic Scholar
Pharmacokinetic-Pharmacodynamic Evidence From a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis OA
Cited by 4
Semantic Scholar
Effectiveness of double-dose dolutegravir in people receiving rifampin-based tuberculosis treatment: an observational, cohort study of people with HIV from six countries.
Cited by 3
Semantic Scholar
Risk-stratified treatment for drug-susceptible pulmonary tuberculosis OA
Cited by 17
Semantic Scholar
Research Topics
Tuberculosis Research and Epidemiology
(98)
Mycobacterium research and diagnosis
(33)
Pneumocystis jirovecii pneumonia detection and treatment
(29)
Pneumonia and Respiratory Infections
(26)
Diagnosis and treatment of tuberculosis
(20)
Affiliations
Uppsala University
Radboud University Nijmegen
University of Cape Town
University of Pittsburgh
University of California, San Francisco